UNICA IRIS Institutional Research Information System

DEL ZOMPO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 273.533
NA - Nord America 14.214
AS - Asia 4.754
SA - Sud America 863
AF - Africa 103
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
Totale 293.494
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 268.952
US - Stati Uniti d'America 14.057
CN - Cina 2.011
SG - Singapore 1.863
NL - Olanda 1.091
UA - Ucraina 1.015
SE - Svezia 767
BR - Brasile 736
DE - Germania 559
GB - Regno Unito 393
FI - Finlandia 354
VN - Vietnam 304
IN - India 130
FR - Francia 124
KR - Corea 107
CA - Canada 83
HK - Hong Kong 72
RU - Federazione Russa 54
MX - Messico 53
AR - Argentina 40
BD - Bangladesh 40
AT - Austria 39
PL - Polonia 39
ZA - Sudafrica 38
BE - Belgio 34
ES - Italia 28
JP - Giappone 28
EC - Ecuador 27
TR - Turchia 27
ID - Indonesia 23
IQ - Iraq 22
CO - Colombia 17
AU - Australia 16
EG - Egitto 16
PK - Pakistan 16
MA - Marocco 14
UZ - Uzbekistan 14
IE - Irlanda 13
IL - Israele 12
CZ - Repubblica Ceca 11
EU - Europa 10
VE - Venezuela 10
AZ - Azerbaigian 9
IR - Iran 9
JO - Giordania 9
KE - Kenya 9
CL - Cile 8
KZ - Kazakistan 8
PY - Paraguay 8
TN - Tunisia 8
BG - Bulgaria 7
MU - Mauritius 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
GR - Grecia 6
LT - Lituania 6
PH - Filippine 6
PT - Portogallo 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
NP - Nepal 5
RO - Romania 5
CH - Svizzera 4
DK - Danimarca 4
DZ - Algeria 4
KG - Kirghizistan 4
PE - Perù 4
QA - Qatar 4
RS - Serbia 4
TW - Taiwan 4
AL - Albania 3
HU - Ungheria 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
MK - Macedonia 2
OM - Oman 2
PR - Porto Rico 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 293.487
Salva come PNG Salva come JPEG
Città #
Cagliari 263.672
Uta 4.583
Fairfield 1.669
Ashburn 1.220
Woodbridge 1.165
Amsterdam 1.070
Chandler 1.012
Houston 885
Singapore 814
Dallas 688
Seattle 659
Wilmington 653
Boardman 643
Ann Arbor 640
Cambridge 532
Jacksonville 518
Nyköping 472
Beijing 385
Dearborn 256
New York 215
Los Angeles 202
Hefei 200
Helsinki 181
Nanjing 179
Santa Clara 179
Boston 165
Shanghai 132
The Dalles 114
Munich 112
Buffalo 109
Seoul 106
San Diego 90
Ho Chi Minh City 83
Shenyang 71
Redwood City 69
Hong Kong 65
Dong Ket 64
Nanchang 61
Hangzhou 59
Atlanta 58
Milan 58
Jiaxing 52
Mountain View 51
São Paulo 51
Norwalk 50
London 45
Verona 45
Changsha 44
Hebei 44
Hanoi 43
Rome 42
Guangzhou 41
Tianjin 39
Redondo Beach 37
Pune 35
Brussels 34
Chicago 34
Jinan 34
Warsaw 34
Montreal 33
Johannesburg 32
Toronto 31
Council Bluffs 30
Rio de Janeiro 30
Frankfurt am Main 29
Orange 28
Zhengzhou 28
Nuremberg 27
Brooklyn 25
Stockholm 25
Denver 24
Vienna 22
Washington 22
Auburn Hills 21
Da Nang 21
Southend 21
Columbus 20
Falls Church 20
Poplar 20
Tokyo 20
Orem 18
Phoenix 18
San Mateo 18
Belo Horizonte 17
Ningbo 17
Sassari 17
Kunming 16
Saint Petersburg 16
San Jose 16
Chennai 14
Mumbai 13
Haiphong 12
Redmond 12
Tashkent 12
Curitiba 11
Detroit 11
Düsseldorf 11
Guarulhos 11
Porto Alegre 11
Quito 11
Totale 285.674
Salva come PNG Salva come JPEG
Nome #
Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness 12.097
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.315
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.226
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.723
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.660
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.599
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.535
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.469
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.465
Continuation versus discontinuation of lithium during pregnancy: a retrospective case series 3.174
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function 3.139
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.100
Dopaminergic and serotonergic genes in bipolar disorder: A case control study in a Sardinian population 3.035
Analysis of the influence of microRNAs in lithium response in bipolar disorder 3.027
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.005
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.991
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.980
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.889
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.876
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.862
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.851
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.831
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.800
Involvement of core clock genes in lithium response 2.782
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.717
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.681
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.646
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.644
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.639
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.630
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.615
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.569
Online information seeking by patients with bipolar disorder: results from an international multisite survey 2.556
null 2.498
Prediction of Lithium Response using Clinical Data 2.453
High leptin levels are associated with migraine with aura 2.439
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? 2.432
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.417
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.397
Pharmacogenomics of bipolar disorder 2.366
Association study in three different populations between the GPR88 gene and major psychoses 2.334
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.332
Internet use by patients with bipolar disorder: Results from an international multisite survey 2.304
Fifteen-year follow-up of thyroid function in lithium patients 2.281
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.276
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.148
Cellular models to study bipolar disorder: a systematic review 2.145
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.123
Solar insolation in springtime influences age of onset of bipolar I disorder 2.102
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 2.085
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 2.052
Association between solar insolation and a history of suicide attempts in bipolar I disorder 2.039
Convergent genetic and expression data implicate immunity in Alzheimer's disease 1.996
null 1.980
Characterisation of age and polarity at onset in bipolar disorder 1.977
Long term lithium treatment and survival from external causes including suicide 1.961
Internet use by older adults with bipolar disorder: international survey results 1.945
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.937
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.906
Clinical factors associated with lithium treatment response in bipolar disorder patients from India 1.862
null 1.842
A genetic risk score is differentially associated with migraine with and without aura 1.819
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.752
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder 1.739
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.717
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.698
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.639
A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness 1.615
Admixture analysis of age at onset in bipolar disorder 1.608
Prediction of lithium response using genomic data 1.605
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.577
Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia 1.570
Farmaci per il trattamento delle cefalee primitive e per il controllo del vomito 1.562
Clozapine toxicity due to a multiple drug interaction: a case report 1.535
null 1.525
Influence of light exposure during early life on the age of onset of bipolar disorder 1.460
null 1.449
null 1.424
null 1.414
Genetic linkage and association studies in affective disorders 1.382
Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study 1.369
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.369
null 1.334
Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes 1.328
Age at Onset in Sardinian Bipolar I Patients: Evidence for Three Subgroups 1.285
Influence of birth cohort on age of onset cluster analysis in bipolar I disorder 1.250
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.232
Six-year follow-up of thyroid function during lithium treatment 1.231
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.213
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.212
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.201
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients 1.199
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.182
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder 1.181
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 1.175
Thyroid abnormalities during lithium treatment 1.173
Evaluation of lithium response in episodic cluster headache: a retrospective case series 1.161
null 1.161
null 1.146
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.139
Totale 225.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 369.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 369.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128.000 0 0 0 0 0 7.632 5.431 4.546 1.576 3.262 3.433 2.120
2021/202214.194 1.828 1.069 802 973 1.113 903 1.028 822 1.259 1.390 1.580 1.427
2022/202320.690 1.579 2.881 2.643 1.777 1.670 2.293 887 1.674 1.569 1.324 1.592 801
2023/202420.950 1.043 1.047 885 1.700 1.899 3.489 2.967 1.300 908 1.333 2.379 2.000
2024/202576.726 26.215 24.066 9.999 4.266 2.622 2.549 3.955 259 520 1.409 400 466
2025/20265.697 765 472 1.451 1.141 1.004 864 0 0 0 0 0 0
Totale 294.068